Cash flows provided by operating activities | |
Net (loss) income | 351.67M |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |
Amortization of net premium on investments | |
Amortization of other intangibles and depreciation | 78.55M |
Net realized gains on investment sales | -33.54M |
Net impairment losses recognized in earnings | 10.65M |
Deferred taxes | |
Stock-based compensation expense | 28.04M |
Equity in earnings of other investments | 201K |
Premiums receivable, net | -888.32M |
Deferred acquisition costs | -56.39M |
Prepaid reinsurance premiums | -327.34M |
Losses recoverable | |
Accrued investment income | 140K |
Other assets | -2.58M |
Reserve for losses and loss expenses | |
Reserve for unearned premiums | 559.42M |
Deposit liabilities | |
Reinsurance balances payable | 357.41M |
Other liabilities | -63.41M |
Net cash provided by operating activities | |
Cash flows used in investing activities: | |
Proceeds from sales of available for sale investments | |
Proceeds from maturities and calls on available for sale investments | |
Proceeds from the redemption of other investments | 246.35M |
Purchases of available for sale investments | -2.39B |
Purchases of other investments | -50.59M |
Net settlements of other assets | -33.62M |
Purchases of fixed assets | -11M |
Change in securities lending collateral received | |
Net cash paid for subsidiary acquisition | -7K |
Net cash flows used in investing activities | |
Cash flows (used in) provided by financing activities | |
Issuance of common shares | 9.55M |
Issuance of series B, non-cumulative preferred shares | |
Repurchase of common shares | |
Change in securities lending payable | |
Settlement of equity awards | |
Offering and registration costs paid | -319K |
Proceeds from issuance of debt | |
Repayments of debt | |
Dividends on preferred shares | -20.15M |
Dividends on common shares | -76.93M |
Net cash (used in) provided by financing activities | |
Effect of exchange rate changes on cash and cash equivalents | 1.99M |
Net increase in cash and cash equivalents | 145.36M |
Cash and cash equivalents, beginning of period | 1.18B |
Cash and cash equivalents, end of period | 1.32B |